theophylline has been researched along with lomefloxacin in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (18.75) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Chen, J; Chen, X; Huang, L; Li, X; Sun, Y | 1 |
| Huang, L; Li, X; Meng, F; Miao, H; Sun, Y | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bai, P; Chen, C; Hu, K; Li, T; Liu, W; Ma, Q; Pan, W; Peng, K; Sang, Z; Yu, L; Zhang, X | 1 |
| Guo, QL; Huang, SL; Huang, ZS; Li, D; Liu, ZQ; Ou, TM; Tan, JH; Wang, HG; Wang, N; Wu, JQ; Xia, CL | 1 |
| An, B; Hu, J; Huang, L; Li, X; Li, Z; Pan, T | 1 |
| Healy, DP; Polk, RE; Schoenle, JR; Stotka, J | 1 |
| Cornel, JH; Martea, M; Vree, TB; Wijnands, GJ | 1 |
| Atkinson, HC; Begg, EJ; Frampton, CM; Robson, RA; Saunders, DA | 1 |
| LeBel, M; St-Laurent, M; Vallée, F | 1 |
| Apichartpichean, R; Hasegawa, T; Kuzuya, T; Muraoka, I; Nadai, M; Takagi, K | 1 |
| Nix, DE; Norman, A; Schentag, JJ | 1 |
| Fuhr, U; Harder, S; Staib, AH; Wack, C | 1 |
| Cantoni, V; Melani, AS; Pirrelli, M; Sarlo, F | 1 |
1 review(s) available for theophylline and lomefloxacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for theophylline and lomefloxacin
| Article | Year |
|---|---|
Lack of interaction between lomefloxacin and caffeine in normal volunteers.
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Caffeine; Double-Blind Method; Drug Interactions; Fluoroquinolones; Half-Life; Humans; Male; Quinolones; Theophylline | 1991 |
Comparative effects of ciprofloxacin and lomefloxacin on the oxidative metabolism of theophylline.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Fluoroquinolones; Humans; Male; Oxidation-Reduction; Quinolones; Random Allocation; Theophylline | 1990 |
13 other study(ies) available for theophylline and lomefloxacin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Inhibition of cholinesterase and monoamine oxidase-B activity by Tacrine-Homoisoflavonoid hybrids.
Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Cholinesterase Inhibitors; Cholinesterases; Electrophorus; Humans; Isoflavones; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Swine; Tacrine | 2013 |
Discovery of indanone derivatives as multi-target-directed ligands against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Drug Design; Humans; Indans; Inhibitory Concentration 50; Ligands; Peptide Fragments; Permeability; Protein Aggregates | 2014 |
Design, synthesis and evaluation of novel ferulic acid-memoquin hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
Topics: Alkanes; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Blood-Brain Barrier; Chemistry Techniques, Synthetic; Cholinesterase Inhibitors; Coumaric Acids; Drug Design; Drug Evaluation, Preclinical; Ethylamines; Humans; Hydrogen Peroxide; Neuroprotective Agents; PC12 Cells; Rats | 2016 |
Design, synthesis and evaluation of 2-arylethenyl-N-methylquinolinium derivatives as effective multifunctional agents for Alzheimer's disease treatment.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Blood-Brain Barrier; Cell Death; Cell Line; Cholinesterase Inhibitors; Drug Design; Glutathione; Humans; Quinolines; Reactive Oxygen Species | 2017 |
Synthesis and evaluation of clioquinol-rolipram/roflumilast hybrids as multitarget-directed ligands for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Aminopyridines; Animals; Benzamides; Clioquinol; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Drug Design; Humans; Ligands; Mice; Rats; Rolipram | 2019 |
The effect of multiple-dose oral lomefloxacin on theophylline metabolism in man.
Topics: 4-Quinolones; Administration, Oral; Adult; Anti-Infective Agents; Drug Administration Schedule; Drug Interactions; Female; Fluoroquinolones; Humans; Injections, Intravenous; Kidney; Male; Quinolones; Theophylline | 1990 |
Influence of lomefloxacin on the pharmacokinetics of theophylline.
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Drug Interactions; Fluoroquinolones; Humans; Male; Metabolic Clearance Rate; Quinolones; Theophylline | 1990 |
Kinetic interaction between theophylline and a newly developed quinolone, NY-198.
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Drug Interactions; Fluoroquinolones; Humans; Male; Quinolones; Theophylline | 1989 |
Effect of lomefloxacin on theophylline pharmacokinetics.
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Drug Interactions; Fluoroquinolones; Half-Life; Humans; Immunoenzyme Techniques; Male; Quinolones; Theophylline | 1989 |
Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acid.
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Chromatography, High Pressure Liquid; Drug Interactions; Fluoroquinolones; Humans; Male; Nicotinic Acids; Pipemidic Acid; Quinolines; Quinolones; Theophylline | 1989 |
Safety and effectiveness of lomefloxacin in patients with acute exacerbation of chronic bronchitis (AECB) chronically treated with oral theophyllines.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Anti-Infective Agents; Bronchitis; Cross-Sectional Studies; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quinolones; Theophylline | 2001 |